Ross, David M. http://orcid.org/0000-0001-7171-2935
,
Pagani, Ilaria S.
Shanmuganathan, Naranie
Kok, Chung H.
Seymour, John F.
Mills, Anthony K.
Filshie, Robin J.
Arthur, Christopher K.
Dang, Phuong
Saunders, Verity A.
Braley, Jodi
Yong, Agnes S.
Yeung, David T.
White, Deborah L.
Grigg, Andrew P.
Schwarer, Anthony P.
Branford, Susan
Hughes, Timothy P.
Funding for this research was provided by:
DMR has received research funding from Novartis and Celgene, and honoraria from Novartis and BMS.
AKM received honoraria from Novartis, BMS, and Specialised Therapeutics.
ASY has received research funding from Novartis, BMS and Celgene, and honoraria from Novartis and BMS.
DTY have received research funding and honoraria from Novartis, BMS, and Ariad.
APG is an advisory board member for Novartis, BMS, Roche, Takeda, and MSD.
APS has received honoraria from Novartis, BMS, Celgene, Roche, Amgen, and Specialised Therapeutics.
SB has received research funding from Novartis, Ariad and Otsuka, honoraria from Novartis, BMS, Otsuka, Qiagen and Ariad, and is an advisory board member for Novartis and Qiagen.
TPH have received research funding and honoraria from Novartis, BMS, and Ariad.
Article History
Received: 19 July 2018
Revised: 16 August 2018
Accepted: 23 August 2018
First Online: 12 October 2018
Compliance with ethical standards
:
: DMR has received research funding from Novartis and Celgene, and honoraria from Novartis and BMS. AKM received honoraria from Novartis, BMS, and Specialised Therapeutics. ASY has received research funding from Novartis, BMS and Celgene, and honoraria from Novartis and BMS. DTY and TPH have received research funding and honoraria from Novartis, BMS, and Ariad. APG is an advisory board member for Novartis, BMS, Roche, Takeda, and MSD. APS has received honoraria from Novartis, BMS, Celgene, Roche, Amgen, and Specialised Therapeutics. SB has received research funding from Novartis, Ariad and Otsuka, honoraria from Novartis, BMS, Otsuka, Qiagen and Ariad, and is an advisory board member for Novartis and Qiagen. The remaining authors declare that they have no conflict of interest.